Lymph Node Harvest of 25+ Improves Survival in Esophageal Cancer
A multicenter study shows that removing at least 25 lymph nodes during surgery for esophageal adenocarcinoma post-chemotherapy leads to better outcomes.
Newsletter
General Surgery
Best Papers in General Surgery
The five that matter, every day.
Robotic Resection Works for Large Central Hepatic Tumors
Robotic liver surgery proves effective for complex resections of benign liver tumors like focal nodular hyperplasia.
Robotic Gastrectomy Cuts Complications in Advanced Gastric Cancer
Robotic gastrectomy significantly lowers severe complications and boosts treatment outcomes in patients with advanced gastric cancer.
New G-CMAP Score Predicts Complications After Gastrectomy
A novel 8-point G-CMAP score can help surgeons predict postoperative complications after gastrectomy for gastric cancer, enhancing patient selection.
Navigating Evidence for Post-Pancreatoduodenectomy Fistulas
Surgeons need to balance level 1 evidence and experiential insight in mitigating pancreatic fistulas after pancreatoduodenectomy.
Radical Resection with Intestinal Autotransplantation Improves Outcomes in Pancreatic Cancer
Surgeons treating locally advanced pancreatic cancer (LAPC) can improve patient survival by using radical resection combined with intestinal autotransplantation after systemic treatment.
Circulating Tumor DNA Predicts Recurrence in Esophageal Cancer
Assessing circulating tumor DNA (ctDNA) in patients with esophageal squamous cell carcinoma (ESCC) identifies high recurrence risk after surgery.
Medicaid Expansion Lowers Death Rate in Colorectal Cancer Patients
Medicaid expansion is linked to improved survival rates in younger colorectal cancer patients with liver metastasis, impacting surgical decision-making.
Language-Savvy Hospitals Cut Readmission for Non-English Patients
Patients with non-English primary languages experience better surgical outcomes at language-serving hospitals compared to non-language-serving ones.
Navigating Neoadjuvant Assessment for Pancreatic Cancer
Assessing neoadjuvant therapy response in pancreatic cancer is crucial for improving surgical outcomes.